| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/04/2004 | US20040043426 Using "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified |
| 03/04/2004 | DE10238742A1 New N-(maleimidyl- or thiohydantoinyl-alkyl)-piperazine derivatives, are androgen receptor destabilizers and/or inhibitors useful e.g. for treating prostate carcinoma or hyperplasia |
| 03/04/2004 | DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 03/04/2004 | CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system |
| 03/04/2004 | CA2496246A1 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 03/04/2004 | CA2496175A1 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/04/2004 | CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | CA2494643A1 Piperidine-n-oxide-derivatives |
| 03/04/2004 | CA2494634A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 03/04/2004 | CA2494263A1 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 03/03/2004 | EP1394160A1 Process for preparing crystalline paroxetin hydrochloride |
| 03/03/2004 | EP1394156A1 Chromene compound |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1392684A1 Thiazole compounds useful as inhibitors of protein kinases |
| 03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 03/03/2004 | EP1392681A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 03/03/2004 | EP1392680A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 03/03/2004 | EP1392679A1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method and intermediate products for the production thereof and medicament containing said compounds |
| 03/03/2004 | EP1392674A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392663A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 03/03/2004 | EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
| 03/03/2004 | EP1392657A2 Protease inhibitors |
| 03/03/2004 | EP1392656A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 03/03/2004 | EP1392655A2 Potassium channel openers |
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392310A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 03/03/2004 | EP1017692B1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/03/2004 | EP0983290B1 Method for producing polymers having nucleo-bases as side-groups |
| 03/03/2004 | EP0882714B1 Substituted vinylpyridine derivatives and drugs containing the same |
| 03/03/2004 | EP0853617B1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 03/03/2004 | EP0841916B9 Endothelin receptor antagonists |
| 03/03/2004 | CN1479760A Epoxy resins, process for production thereof, epoxy resin compositions and crured articles |
| 03/03/2004 | CN1479728A Pexoxisome proliferator activated receptor alpha agonists |
| 03/03/2004 | CN1479727A Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 03/03/2004 | CN1479618A Treatment of sexual dysfunction using boonbesin antagonist |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 03/03/2004 | CN1140522C Benzodihydropyran derivative |
| 03/03/2004 | CN1140516C Quinoline and quinoxaline compounds which inhibits platelet-derived growth factor on/or p56lck tyrosine kinases |
| 03/03/2004 | CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators |
| 03/02/2004 | US6700013 O-bromophenylacetic acid derivative chemical intermediate; smooth muscle relaxants, antiinflammatory agents; respiratory system disorders |
| 03/02/2004 | US6699890 Phosphodiesterase 4 inhibitors |
| 03/02/2004 | US6699881 Thiol compounds, their production and use |
| 03/02/2004 | US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699864 Substituted phenyl-piperazine derivatives, their preparation and use |
| 03/02/2004 | US6699863 Regulate, modulate and/or inhibit abnormal cell proliferation. |
| 03/02/2004 | US6699860 Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists |
| 03/02/2004 | US6699858 Halogen substituted tetracyclic tetrahydrofuran derivatives |
| 03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
| 03/02/2004 | US6699818 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 02/26/2004 | WO2004016607A1 Inhibition of phosphoinositide 3-kinase beta |
| 02/26/2004 | WO2004016606A1 Pyrazole inhibitors of the transforming growth factor |
| 02/26/2004 | WO2004016597A2 Protein kinase inhibitors and uses thereof |
| 02/26/2004 | WO2004016587A1 Nitrogen-containing compounds |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | WO2004016271A1 Pyrimidones as antiviral agents |
| 02/26/2004 | WO2003101444A8 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer |
| 02/26/2004 | WO2003096991A3 Amelioration of the development of cataracts and other opthalmic diseases |
| 02/26/2004 | WO2003076398A3 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors |
| 02/26/2004 | WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof |
| 02/26/2004 | WO2003050261A3 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| 02/26/2004 | WO2002098869A3 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | WO2002081491A3 New genistein derivatives and pharmaceutical preparations containing them |
| 02/26/2004 | WO2002041910A8 Methods and compositions for the treatment of diseases of the eye |
| 02/26/2004 | US20040039198 Administering to a mammal an aromatic and heteroacromatic substituted imidazole compound to treat diseases: renal disease, wound healing, ucler, ocular disorder, diabetic nephropathy, atherosclerosis, fibrosis, ALzheimer's disease |
| 02/26/2004 | US20040039060 Capable of chelating both of the two divalent metal ions at the same time, a prodrug or a solvate |
| 02/26/2004 | US20040039044 Coupling under reducing conditions aminoalkylpyrrolidine-n-alkyl with one equivalant of a aldehyde compound; useful for treating pain, schizophrenia, depression and sleep disorders |
| 02/26/2004 | US20040039041 Using an alfa2-adrenoceptor antagonist or an ester or salt selected from atipamezole, idazoxan, efaroxan or their salts, to prevent dyskinesias caused by chronic use of dopaminergic agents while treting neuropsychiatric disorders |
| 02/26/2004 | US20040039033 Administering (1-phenyl-2-heteroaryl)ethyl-guanidine compounds for treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias |
| 02/26/2004 | US20040039028 Nitrogen compounds such as 3,5-dichloro-2-fluoro-4-(3-isoprop -yl-4-methoxyphenoxy)-6-methoxycarbonylmethylaminopyridine, administered for prophylaxis of metabolic disorders |
| 02/26/2004 | US20040039026 Macromolecules such as (12R,13S,15S)-cyclopropyl 5-methyl-pyridine epothilone A, used as tubulin polymerization promoters and for cytolysis cancer cells; antiproliferative agents |
| 02/26/2004 | US20040039023 Therapeutic agents |
| 02/26/2004 | US20040039019 Hetreocyclic carboxy amines such as N-(2-Oxo-2,3-dihydro-1H-indol-6-yl)-2-((6-oxo-1,6-dihydro-pyridin-3 -ylmethyl)-amino)-benzamide, used for prophylaxis of arthritis, vision defects, diabetes, arteriosclerosis, skin or urogenital disorders |
| 02/26/2004 | US20040039017 Heterocyclic amines such as 2-(3-(4-Chloro-3-trifluoromethyl-benzylamino)prop-1-ylamino)-1H-quinolin-4 -one, used as G-protein coupled receptor inhibitors, for prophylaxis of cardiovascular disorders, schizophrenia or diabetes |
| 02/26/2004 | US20040039016 HIV protease inhibitors |
| 02/26/2004 | US20040039008 Peroxy compounds such as adamantane-2-spiro-3'-8'-((1'S)-10'-camphorsulfonyl)-1',2',4'-trioxa-8' -azaspiro(4.5)decane, used for prophylaxis of malaria or schistosomiasis infections |
| 02/26/2004 | US20040038998 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity |
| 02/26/2004 | US20040038991 Imidazolyl-cyclic acetals |
| 02/26/2004 | US20040038989 (S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals, useful as intermediates for the preparation of levodropropizine |
| 02/26/2004 | US20040038986 E.g., 4-(6-chloronaphthalene-2-sulfonyl)-1-(4-methoxy-carbonylamino-1-(4 -pyridyl)piperidin-4-ylmethyl)-2-piperazinone; blood coagulation factor X inhibitors |
| 02/26/2004 | US20040038979 Novel 6-heteroarylphenanthridines |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 02/26/2004 | US20040038973 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038972 1,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038965 Protease inhibitors |
| 02/26/2004 | US20040038964 Imidazole derivatives as raf kinase inhibitors |
| 02/26/2004 | US20040038957 Anti-malarial activity |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/26/2004 | US20040038350 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner |
| 02/26/2004 | US20040035293 Melt point is < 100 degrees c; provides distinct selectivities and reactivities because they are made of ions rather than molecules |